Defining peptide sequences: From antigenicity to immunogenicity through redundancy

Current Pharmacogenomics

Volumn 4, Issue 1, 2006, Pages 33-37

  Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmune diseases; Disease associated proteins (DAPs); Epitopes; MHC binding motifs; Vaccine immunobiology

Indexed keywords

AMINO ACID; CANCER VACCINE; EPITOPE; IMMUNOMODULATING AGENT; PEPTIDE; TUMOR VACCINE;

ALGORITHM; ANTIGENICITY; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; DEGENERATIVE DISEASE; DRUG EFFICACY; EXPERIMENTAL DESIGN; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; PREDICTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; REDUNDANCY ANALYSIS; REVIEW; SEQUENCE ANALYSIS;

EID: 33646131438     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016006776055374     Document Type: Review

References (56)

1. Alexander, C.; Kay, A. B. and Larche, M. (2002) Peptide-based vaccines in the treatment of specific allergy. Curr. Drug Targets Inflamm. Allergy 1, 353-361.
2. American Cancer Association. Cancer Statistics (2005) www.cancer.org.
3. Bailar, J. C. 3rd. and Gornik, H. L. (1997) Cancer undefeated. N. Engl. J. Med. 36, 1569-1574.
4. Bankovich, A. J. and Garcia, K. C. (2003) Not just any T cell receptor will do. Immunity 18, 7-11.
5. Barth, A.; Hoon, D. S. B.; Foshag, L. J.; Nizze, J. A.; Famatiga, E.; Okun, E. and Morton, D. L. (1994) Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response. Cancer Res. 54, 3342-3345.
6. Beignon, A. S.; Brown, F.; Eftekhari, P.; Kramer, E.; Briand, J. P.; Muller, S. and Partidos, C. D. (2005) A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses. Vet. Immunol. Immunopathol. 104, 273-280.
7. Brusic, V.; Petrovsky, N.; Zhang, G. and Bajic, V. (2002) Prediction of promiscuous peptides that bind HLA class I molecules. Immunol. Cell Biol. 80, 280-285.
8. Brusic, V.; Rudy, G.; Honeyman, G.; Hammer, J. and Harrison, L. (1998) Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 14, 121-130.
9. Carbone, D. P.; Ciernik, I. F.; Kelley, M. J.; Smith, M. C.; Nadaf, S.; Kavanaugh, D.; Maher, V. E.; Stipanov, M.; Contois, D.; Johnson, B. E.; Pendleton, C. D.; Seifert, B.; Carter, C.; Read, E. J.; Greenblatt, J.; Top, L. E.; Kelsey, M. I.; Minna, J. D. and Berzofsky, J. A. (2005) Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. J. Clin. Oncol. 23, 5099-5107.
10. Chianese-Bullock, K. A.; Pressley, J.; Garbee, C.; Hibbitts, S.; Murphy, C.; Yamshchikov, G.; Petroni, G. R.; Bissonette, E. A.; Neese, P. Y.; Grosh, W. W.; Merrill, P.; Fink, R.; Woodson, E. M.; Wiernasz, C. J.; Patterson, J. W. and Slingluff, C. L. Jr. (2005) MAGE-A1, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma. J. Immunol. 174, 3080-3086.
11. Chou, P. Y. and Fasman, G. D. (1979) Prediction of beta-turns. Biophys. J. 26, 367-373.
12. Dummer, R.; Mittelman, A.; Fanizzi, F. P.; Lucchese, G.; Willers, J. and Kanduc, D. (2004) Non-self discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients. Int. J. Cancer. 111, 720-726.
13. Engelman, D. M.; Steitz, T. A. and Goldman, A. (1986) Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Ann. Rev. Biophys. Biophys. Chem. 15, 321-353.
14. Ferrone, S. and Kageshita, T. (1988) Human high molecular weight-melanoma associated antigen as a target for active specific immunotherapy - a phase I clinical trial with murine antiidiotypic monoclonal antibodies. J. Dermatol. 15, 457-465.
15. Harlow, E. (1994) An introduction to the puzzle. Cold Spring Harb. Symp. Quant. Biol, 59, 709-723.
16. Hemmer, B.; Kondo, T.; Gran, B.; Pinilla, C.; Cortese, I.; Pascal, J.; Tzou, A.; McFarland, H. F.; Houghten, R. and Martin, R. (2000) Minimal peptide length requirements for CD4(+) T cell clones-implications for molecular mimicry and T cell survival. Int. Immunol. 12, 375-383.
17. Hopp, T. P. and Woods, K. R. (1983) A computer program for predicting protein antigenic determinants. Mol. Immunol. 20, 483-489.
18. Istrail, S.; Sutton, G. G.; Florea, L.; Halpern, A. L.; Mobarry, C. M.; Lippert, R.; Walenz, B.; Shatkay, H.; Dew, I.; Miller, J. R.; Flanigan, M. J.; Edwards, N. J.; Bolanos, R.; Fasulo, D.; Halldorsson, B. V.; Hannenhalli, S.; Turner, R.; Yooseph, S.; Lu, F.; Nusskern, D. R.; Shue, B. C.; Zheng, X. H.; Zhong, F.; Delcher, A. L.; Huson, D. H.; Kravitz, S. A.; Mouchard, L.; Reinert, K.; Remington, K. A.; Clark, A. G.; Waterman, M. S.; Eichler, E. E.; Adams, M. D.; Hunkapiller, M. W.; Myers, E. W. and Venter, J. C. (2004) Whole-genome shotgun assembly and comparison of human genome assemblies. Proc. Natl. Acad. Sci. USA 101, 1916-1921.
19. Jung, G.; Fleckenstein, B.; von der Mülbe, F.; Wessels, J.; Niethammer, D. and Wiesmüller, K. -H. (2001) From combinatorial libraries to MHC ligand motifs, T-cell superagonists and antagonists. Biologicals 29, 179-181.
20. Kaliyaperumal, A.; Michaels, M. A. and Datta, S. K. (1999) Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol. 162, 5775-5783.
21. Kanduc, D.; Lucchese, A. and Mittelman, A. (2001) Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology. Peptides 22, 1981-1985.
22. Kanduc, D.; Capuano, F.; Capurso, S. A.; Geliebter, J.; Guercia, D.; Lucchese, A.; Mittelman, A.; Simone, S. M.; Sinha, A. A.; Tiwari, R. and Farber, E. (2003) Cancer prevention and therapy: strategies and problems. J. Exp. Ther. Oncol. 3, 108-114.
23. Kanduc, D.; Fanizzi, F. P.; Lucchese, G.; Stevanovic, S.; Sinha, A. A. and Mittelman, A. (2004) NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope. Peptides 25, 243-250.
24. Lamont, A. G.; Sette, A.; Fujinami, R.; Colon, S. M.; Miles, C. and Grey, H. M. (1990) Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules. J. Immunol. 145, 1687-1693.
25. Larche, M.; Wraith, D. C. (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 11, S69-S76.
26. Letsch, A.; Keilholz, U.; Fluck, M.; Nagorsen, D.; Asemissen, A. M.; Schmittel, A.; Thiel, E. and Scheibenbogen, C. (2005) Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients. Int. J. Cancer. 114, 936-941.
27. Lindner, K.; Mole, S. E.; Lane, D. P. and Kenny, M. K. (1998) Epitope mapping of antibodies recognising the N-terminal domain of simian virus large tumour antigen. Intervirology 41, 10-16.
28. Livingston, P. O.; Natoli, E. J. Jr.; Calves, M. J.; Stockert, E.; Oettgen, H. F. and Old, L. (1987) Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc. Natl. Acad. Sci. USA 84, 2911-2915.
29. Lu, J.; Higashimoto, Y.; Appella, E. and Celis, E. (2004) Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses. J. Immunol. 172, 4575-4582.
30. Lucchese, A.; Mittelman, A.; Lin, M. S.; Kanduc, D. and Sinha, A. A. (2004) Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10. J. Transl. Med. 2, 43.
31. Lucchese, A.; Stevanovic, S.; Sinha, A. A.; Mittelman, A. and Kanduc, D. (2003) Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope. Peptides 24, 193-197.
32. Manavalan, P. and Ponnuswamy, P. K. (1978) Hydrophobic character of amino acid residues in globular proteins. Nature 275, 673-674.
33. May, A. C. (2004) Percent sequence identity; the need to be explicit. Structure. 12, 737-738.
34. Mitchell, M.; Harel, W.; Kan-Mitchell, J.; LeMay, L. G.; Goedegebuure, P.; Huang, X. Q.; Hofman, F. and Groshen, S. (1993) Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action. Ann. N.Y. Acad. Sci. 690, 153-166.
35. Mittelman, A.; Tiwari, R.; Lucchese, G.; Willers, J.; Dummer, R. and Kanduc, D. (2004) Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining. J. Invest. Dermat. 123, 670-675.
36. Mocellin, S.; Rossi, C. R.; Nitti, D.; Lise, M. and Marincola, F. M. (2003) Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. Biochim. Biophys. Acta 1653, 61-71.
37. Monsonego, A. and Weiner, H. L. (2003) Immunotherapeutic approaches to Alzheimer's disease. Science 302, 834-838.
38. Natale, C.; Giannini, T.; Lucchese, A. and Kanduc, D. (2000) Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol. Cell Biol. 78, 580-585.
39. Nielsen, M. B. and Marincola, F. M. (2000) Melanoma vaccines: the paradox of T cell activation without clinical response. Cancer Chemother. Pharmacol. 46, S62-S66.
40. Rammensee, H.; Bachmann, J.; Emmerich, N. P.; Bachor, O. A. and Stevanovic, S. (1999) SYFPEITHI: database for MHC ligands; peptide motifs. Immunogenetics 50, 213-219.
41. Rechtsteiner, G.; Warger, T.; Osterloh, P.; Schild, H. and Radsak, M. P. (2005) Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. J. Immunol. 174, 2476-2480.
42. Reddehase, M. J.; Rothbard, J. B. and Koszinowski, U. H. (1989) A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337, 651-653.
43. Roberts, C. G.; Meister, G. E.; Jesdale, B. M.; Lieberman, J.; Berzofsky, J. A. and De Groot, A. S. (1996) Prediction of HIV peptide epitopes by a novel algorithm. AIDS Res. Hum. Retroviruses 12, 593-610.
44. Rosenberg, S. A. (1999) A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10, 281-287.
45. Sturniolo, T.; Bono, E.; Ding, J.; Raddrizzani, L.; Tuereci, O.; Sahin, U.; Braxenthaler, M.; Gallazzi, F.; Protti, M. P.; Sinigaglia, F. and Hammer, J. (1999) Generation of tissue-specific; promiscuous HLA ligand databases using DNA microarrays; virtual HLA class II matrices. Nature Biotech. 17, 555-561.
46. Sweet, R. M. and Eisenberg, D. (1983) Correlation of sequence hydrophobicities measures similarity in three-dimensional protein structure. J. Mol. Biol. 171, 479-488.
47. Thornton, J. M.; Edwards, M. S.; Taylor, W. R. and Barlow, D. J. (1986) Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J. 5, 409-413.
48. van Regenmortel, M. H. V. (2002) A paradigm shift is needed in proteomics: 'structure determines function' should be replaced by 'binding determines function'. J. Mol. Recognit. 15, 349-351.
49. van Regenmortel, M. H. V. (2000) The recognition of proteins; peptides by antibodies. J. Immunoassay 21, 85-108.
50. van Regenmortel, M. H. V. (2001) Antigenicity; immunogenicity of synthetic peptides. Biologicals 29, 209-213.
51. Vihinen, M.: Torkkila, E. and Riikonen, P. (1994) Accuracy of protein flexibility predictions. Proteins 19, 141-149.
52. Wang, C. Y. and Walfield, A. M. (2005) Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications. Vaccine 23, 2049-2056.
53. Willers, J.; Lucchese, A.; Mittelman, A.; Dummer, R., and Kanduc, D. (2005) Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp. Dermatol. 14, 543-550.
54. Wu, C. H.; Huang, H.; Arminski, L.; Castro-Alvear, J.; Chen, Y.; Hu, Z. -Z.; Ledley, R. S.; Lewis, K. C.; Mewes, H. -W.; Orcutt, B. C.; Suzek, B. E.; Tsugita, A.; Vinayaka, C. R.; Yeh, L. -S. L.; Zhang, J. Barker, W. C. (2002) The Protein Information Resource: an integrated public resource of functional annotation of proteins. Nucleic Acids Res. 30, 35-37.
55. Yu, K.; Petrovsky, N.; Schonbach, C.; Koh, J. Y. and Brusic, V. (2002) Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol. Medicine 8, 137-148.
56. Yu, Z. and Restifo, N. P. (2002) Cancer vaccines: progress reveals new complexities. J. Clin. Invest. 110, 289-294.